Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma

E-ISSN： 1545-5017|65|4|pbc.26902-pbc.26902

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.65, Iss.4, 2018-04, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

ALK‐positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient

JOURNAL OF CUTANEOUS PATHOLOGY, Vol. 42, Iss. 3, 2015-03 ,pp. : 182-187

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cutaneous involvement in systemic anaplastic large cell lymphoma

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol. 13, Iss. 7, 2015-07 ,pp. : 693-694

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary Cerebral ALK-1-Positive Anaplastic Large Cell Lymphoma in a Child

Pediatric Neurosurgery, Vol. 43, Iss. 6, 2007-11 ,pp. : 516-521

Karger

Access to resources Recommend Favorite

ALK‐positive anaplastic large cell lymphoma with prominent bone involvement

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 4, 2015-08 ,pp. : 443-443

John Wiley & Sons Inc

Access to resources Recommend Favorite

ALK‐positive anaplastic large cell lymphoma presenting with hemophagocytic lymphohistiocytosis

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 8, 2015-08 ,pp. : 746-747

John Wiley & Sons Inc

Access to resources Recommend Favorite